SCHEMBL17953771

SCHEMBL17953771

c1ccc(-n2c3ccccc3c3cc(-c4ccc5cc(-c6ccc7c8c(cccc68)-c6ccccc6-7)ccc5c4)ccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
KDM4E B2RXH2 2/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 4/20 0.35
PTGER4 P35408 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
HIF1A Q16665 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TSPO P30536 4/20 0.34
KEAP1 Q14145 2/20 0.33
NFE2L2 Q16236 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
NTSR1 P30989 1/20 0.32
MET P08581 1/20 0.32
HDAC4 P56524 1/20 0.32
KMT2A Q03164 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15479987 0.96 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL15480206 0.95 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL17953663 0.94 L3MBTL1 (0.51) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL15480205 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL15480041 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL15480207 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL17953774 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL15480343 0.92 L3MBTL1 (0.47) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL17953789 0.92 L3MBTL1 (0.47) L3MBTL1KDM4EATMALDH1A1PTGER4
SCHEMBL17953853 0.92 L3MBTL1 (0.47) L3MBTL1KDM4EATMALDH1A1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10622569-B2 Compound, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-04-14 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EFNA1, L1CAM, LEF1 L3MBTL1 1706/4885KDM4E 2030/4885ATM 3520/4885
US-10622569-B2 Compound, organic electroluminescent element, and electronic device EFNA1, L1CAM, LEF1 L3MBTL1 1706/4885KDM4E 2030/4885ATM 3520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.